BRAF and melanoma: This may indicate that the synergistic effects seen of intratumoral poly(I:C) with checkpoint blockade and BRAF inhibition in mouse models of melanoma may be at least partially due to the increased activation of antigen bearing mDC and rDC within the lymph node (36).